Numinus wellness inc

Financial Times Close. Search the FT Search. Show more World link World.

Numinus Wellness Inc. The capital raise is another important step for the mental health care company, which focuses on developing psychedelic-assisted therapies. The financing round also saw contributions from venture fund Integrated V. We see Numinus as playing a critical role in ensuring that therapists have the option to volunteer for experiential training to become fully trained on the latest medicines and their therapeutic methodologies. Scheduled to close around Feb. According to the Numinus, the proceeds from the offering are intended for working capital and general corporate purposes.

Numinus wellness inc

Search Search for:. CAN US. Book A call Get support on your path to wellness. I need help with I want information about Who We Are At Numinus, we're shaping a new path to wellness with psychedelic-assisted therapy and a range of mental health treatments. Our holistic, integrated approach to healing, combines the latest advances in medicine with the best in evidence-based care. Learn More Watch Video. What We Offer Mental Health Services Robust, accessible, end-to-end treatment options that can help, no matter where you are in your journey. Training with Numinus Learn from the experts. We offer premium psychedelic-assisted therapy training for licensed and non-licensed providers.

The financing round also saw contributions from venture fund Integrated V. Braxia Scientific cash dwindles even as revenues rise. Add to Your Portfolio New portfolio.

.

Launched the Numinus Certification Pathway to train and certify psychedelic therapy practitioners, with over unique learners participating since inception. Facilitated 36 clinical research trials inclusive of many leading psychedelic drug development companies. Since Numinus was founded, there have been significant advancements in psychedelic therapy, and we take pride in our substantial contributions to this sector that positively impact people's lives. The results of our efforts can be seen in the increasing number of client visits, our research collaborations with leading drug developers and the growth of our training platform for practitioners. The anticipated approval of MDMA-assisted therapy by the FDA, if approved, will provide us with increased opportunities to deploy our unique service model using another treatment modality. We are migrating our courses to a new Learning Management System, enhancing our training program by significantly improving learner engagement, satisfaction, ease of navigation and overall community experience. Additionally, our new free Introduction to Psychedelics course will be launched in the next two weeks to help broaden the awareness of the benefits of PAT while also providing greater brand awareness and lead generation for the full program. With the anticipation of MDMA-AT approval next year, this training is crucial to ensure positive client outcomes and rapid adoption of this treatment option. Revenues grew 1.

Numinus wellness inc

Search Search for:. CAN US. Book A call Get support on your path to wellness. I need help with I want information about Who We Are At Numinus, we're shaping a new path to wellness with psychedelic-assisted therapy and a range of mental health treatments. Our holistic, integrated approach to healing, combines the latest advances in medicine with the best in evidence-based care. Learn More Watch Video.

Vikram vedha telugu dubbed movierulz

Vancouver Client. All rights reserved. Show more US link US. Open 0. I want information about Actions Add to watchlist Add to portfolio Add an alert. US CAN. Fluent Form. Related Articles. The financing drew support from a cohort that includes MAPS.

In connection with the Offering, Numinus has secured a lead order from Integrated V.

Looking to become a certified psychedelic Therapist? Our flexible certification pathway was designed with your busy schedule in mind. Learn More. Sign Up. Use our equities screener to discover other potential opportunities. What Are Psychedelics? Compass widens Q4 loss as patient hurdles slow trials. Open 0. Leave a Reply Cancel Reply Your email address will not be published. Show more Tech link Tech. They include certain types of plants and fungi, as well as synthetic compounds. I need help with I want information about Short selling activity Low. Braxia Scientific cash dwindles even as revenues rise.